Recurrent panniculitis in a man with asthma receiving treatment with leukotriene-modifying agents.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10852428.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Leukotriene-modifying drugs are novel agents introduced recently to treat asthma. Both 5-lipoxygenase inhibitors, such as zileuton, and leukotriene receptor antagonists, such as zafirlukast and montelukast, have proved effective in the treatment of asthma. To our knowledge, there have been no detailed reports regarding dermatologic manifestations of this class of drugs. This article describes an unusual case of erythema nodosum in a 46-year-old asthmatic man who received 2 different leukotriene modifiers.
Medical subject headings
- Acetates
- Anti-Asthmatic Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Asthma
- Erythema Induratum
- Hydroxyurea
- Leukotriene Antagonists
- Lipoxygenase Inhibitors
- Panniculitis, Nodular Nonsuppurative
- Quinolines